These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11359952)

  • 21. [The modeling of interactions of the CYP2E1 isoform of human cytochrome P450 with substrates].
    Potemkin VA; Grishina MA; Bartashevich EV; Zrakova TIu; Pogrebnoĭ AA
    Biofizika; 2005; 50(3):418-22. PubMed ID: 15977830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aromatic hydroxylation by cytochrome P450: model calculations of mechanism and substituent effects.
    Bathelt CM; Ridder L; Mulholland AJ; Harvey JN
    J Am Chem Soc; 2003 Dec; 125(49):15004-5. PubMed ID: 14653732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure and chemistry of cytochrome P450.
    Denisov IG; Makris TM; Sligar SG; Schlichting I
    Chem Rev; 2005 Jun; 105(6):2253-77. PubMed ID: 15941214
    [No Abstract]   [Full Text] [Related]  

  • 24. Ipso-substitution by cytochrome P450 with conversion of p-hydroxybenzene derivatives to hydroquinone: evidence for hydroperoxo-iron as the active oxygen species.
    Vatsis KP; Coon MJ
    Arch Biochem Biophys; 2002 Jan; 397(1):119-29. PubMed ID: 11747318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for cytochrome p450 reactivity by harnessing catalase as reporter enzyme.
    Rabe KS; Spengler M; Erkelenz M; Müller J; Gandubert VJ; Hayen H; Niemeyer CM
    Chembiochem; 2009 Mar; 10(4):751-7. PubMed ID: 19241405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural rationalization of novel drug metabolizing mutants of cytochrome P450 BM3.
    Stjernschantz E; van Vugt-Lussenburg BM; Bonifacio A; de Beer SB; van der Zwan G; Gooijer C; Commandeur JN; Vermeulen NP; Oostenbrink C
    Proteins; 2008 Apr; 71(1):336-52. PubMed ID: 17957765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alkane hydroxylation by peroxy acids: a comparison with the cytochrome P450 hydroxylation.
    Groenhof AR; Ehlers AW; Lammertsma K
    J Phys Chem A; 2008 Dec; 112(50):12855-61. PubMed ID: 18956858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
    Shimada T; Mernaugh RL; Guengerich FP
    Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active species of horseradish peroxidase (HRP) and cytochrome P450: two electronic chameleons.
    de Visser SP; Shaik S; Sharma PK; Kumar D; Thiel W
    J Am Chem Soc; 2003 Dec; 125(51):15779-88. PubMed ID: 14677968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.
    Cupp-Vickery JR; Garcia C; Hofacre A; McGee-Estrada K
    J Mol Biol; 2001 Aug; 311(1):101-10. PubMed ID: 11469860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Much anticipated--the bioactive conformation of epothilone and its binding to tubulin.
    Heinz DW; Schubert WD; Höfle G
    Angew Chem Int Ed Engl; 2005 Feb; 44(9):1298-301. PubMed ID: 15714588
    [No Abstract]   [Full Text] [Related]  

  • 32. Purification and characterization of benzoate-para-hydroxylase, a cytochrome P450 (CYP53A1), from Aspergillus niger.
    Faber BW; van Gorcom RF; Duine JA
    Arch Biochem Biophys; 2001 Oct; 394(2):245-54. PubMed ID: 11594739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Forms and functions of cytochrome P450.
    Stegeman JJ; Livingstone DR
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Nov; 121(1-3):1-3. PubMed ID: 9972446
    [No Abstract]   [Full Text] [Related]  

  • 34. Kinetic isotope effect is a sensitive probe of spin state reactivity in C-H hydroxylation of N,N-dimethylaniline by cytochrome P450.
    Li C; Wu W; Kumar D; Shaik S
    J Am Chem Soc; 2006 Jan; 128(2):394-5. PubMed ID: 16402810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An introduction to the cytochrome P450s.
    Estabrook R
    Mol Aspects Med; 1999; 20(1-2):5-12, 13-137. PubMed ID: 10575647
    [No Abstract]   [Full Text] [Related]  

  • 36. Focus on molecules: cytochrome P450 family 4, subfamily V, polypeptide 2 (CYP4V2).
    Mackay DS; Halford S
    Exp Eye Res; 2012 Sep; 102():111-2. PubMed ID: 21745470
    [No Abstract]   [Full Text] [Related]  

  • 37. Structural biology of p450-oxy complexes.
    Poulos TL
    Drug Metab Rev; 2007; 39(2-3):557-66. PubMed ID: 17786638
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytochrome P450 enzymes.
    Meyer UA
    Drug Metabol Drug Interact; 2012; 27(1):1-2. PubMed ID: 22718619
    [No Abstract]   [Full Text] [Related]  

  • 39. The molecular perspective: cytochrome p450.
    Goodsell DS
    Oncologist; 2001; 6(2):205-6. PubMed ID: 11306732
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular advances for the cytochrome P-450 superfamily.
    Guengerich FP
    Trends Pharmacol Sci; 1991 Aug; 12(8):281-3. PubMed ID: 1949194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.